Birdwatch Note
2022-10-17 20:57:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The K18-hACE2 mice used in this study are highly susceptible to SARS-CoV-2 and have a 100% mortality rate when infected with the wild-type virus. While the chimeric virus resulted in an 80% mortality rate, these numbers do not translate to real-world outcomes. https://doi.org/10.1101/2022.10.13.512134 https://doi.org/10.1038/s41586-022-04442-5 https://twitter.com/mbeisen/status/1582089949242740736
Written by DA4507E4409ABAABB16D1F142ADEA36B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1582034277524332544
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1582113678425473027
- noteId - 1582113678425473027
- participantId - DA4507E4409ABAABB16D1F142ADEA36B
- noteAuthorParticipantId -
- createdAtMillis - 1666040269845
- tweetId - 1582034277524332544
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - CHALLENGING
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The K18-hACE2 mice used in this study are highly susceptible to SARS-CoV-2 and have a 100% mortality rate when infected with the wild-type virus. While the chimeric virus resulted in an 80% mortality rate, these numbers do not translate to real-world outcomes. https://doi.org/10.1101/2022.10.13.512134 https://doi.org/10.1038/s41586-022-04442-5 https://twitter.com/mbeisen/status/1582089949242740736
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-10-17 20:57:49 UTC (1666040269845) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | ||
2022-10-17 20:57:49 UTC (1666040269845) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
DA4507E4409ABAABB16D1F142ADEA36B |
Note Ratings
rated at | rated by | |
2022-10-17 21:01:00 -0500 | 01DF201C52767D83BAF920EF7D74AA42FA52DF7AD4732C527FD1EDEC2F8AF77A | Rating Details |
2022-10-17 19:40:09 -0500 | 03C7CB82FBDE07C71DB78B7B8D2381E69DD4DA37A2F6E74172184C68E111CAB3 | Rating Details |
2022-10-18 16:54:55 -0500 | 0BCC8F4EE9F96B62C8CE9F9E71A8A3F6A09BED06241E7971BB08EAC4E35C379E | Rating Details |
2022-10-18 07:10:36 -0500 | 1580899F22373DC3BE4415B2034FF3F4 | Rating Details |
2022-10-17 20:59:23 -0500 | 2406781FA1BD964624955C8DAEF819BC1B49BE1555AEE29F2465DDC07EF3B790 | Rating Details |
2022-10-18 07:54:01 -0500 | 2754E43902F81C4806F6CADF1821C1140150605963B6061F2F6C4FC69B6B16C1 | Rating Details |
2022-10-17 18:57:04 -0500 | 31FB79A53AE9E1FA6FB3440FD0549F856D1187F07960AEDD3E4D088170F103BE | Rating Details |
2022-10-18 07:54:01 -0500 | 323A238ED38E815CDF07234A7E558A69 | Rating Details |
2022-10-17 23:23:06 -0500 | 3C6AFB37FD0EBF6AEA4DE1544BD7CB6E | Rating Details |
2022-10-17 20:59:23 -0500 | 43688909D9263B9CAF3C33439A3C91E3 | Rating Details |
2022-10-18 13:55:46 -0500 | 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 | Rating Details |
2022-10-17 17:19:06 -0500 | 495FF1E1B3FA1CE5D71C94B60635343CA237AAE157C9512239D5BAA6B14A9D70 | Rating Details |
2022-10-18 07:10:36 -0500 | 5566D48357990D7AD50D26CC80C51D9E8601FF929790CB8C806B8272E4B332DF | Rating Details |
2022-10-17 19:40:09 -0500 | 576F7A772D83A973E8C2CEF43B585D29 | Rating Details |
2022-10-17 19:39:15 -0500 | 58794DC7272F18681D4FBCB1A501409630B2E04983DB5205C7C045C14031589E | Rating Details |
2022-10-17 19:39:15 -0500 | 5B57D8B8DAC2F6FE8155EA1ACD8A3495 | Rating Details |
2022-10-18 08:53:19 -0500 | 65D2E5B877DB7B3C12B757F19D392C8F | Rating Details |
2022-10-18 02:07:26 -0500 | 929E11C8C7B27C492E0F8533E1147F38 | Rating Details |
2022-10-18 16:54:55 -0500 | 9D39800433470057FBA3FE934C493506 | Rating Details |
2022-10-17 16:43:40 -0500 | 9E497DA6496E3D1DED97E90ECB9B0F3AAE41F9005CABCF2491B9700AA69C7C6C | Rating Details |
2022-10-17 17:19:06 -0500 | A33A87A5D8766C4F024541BE827E020D | Rating Details |
2022-10-18 09:13:30 -0500 | AB109B8315B86F7F5CC758E7D35E92F4 | Rating Details |
2022-10-17 16:43:40 -0500 | AD509BE8643AF4453B689D37986118E5 | Rating Details |
2022-10-17 23:23:06 -0500 | BFFB44097E33F48857494B65D7B491A91C5CD1660F947DDAD49B99749EF67E88 | Rating Details |
2022-10-18 13:55:46 -0500 | CD9D49DCCCDDE369B34482B66E49E224 | Rating Details |
2022-10-18 02:07:26 -0500 | D46BFDAC32CFD9D03CD0092619AD7AD567D6DF1C145B50A11053C5AFE8CCAF7D | Rating Details |
2022-10-17 21:01:00 -0500 | D5C1C09C76E24131B5D3037B5C0D666F | Rating Details |
2022-10-22 19:50:42 -0500 | DE20B9CC54BECBF14B931ECA299DFB0B036FC3DF648195823FD7948A52788BD1 | Rating Details |
2022-10-22 19:50:42 -0500 | E069D2851EC25B4D7271459BF2E83220 | Rating Details |
2022-10-18 09:13:30 -0500 | E06ADF3E03EF3874B97D3F6F891E5884B0866FB55A0F9057FD55F2AD91D28A46 | Rating Details |
2022-10-17 21:34:37 -0500 | F092EA4CB202B72F79AC43DE5CAF2DC7D60778EB0698DDEA8AB3EED4323C2245 | Rating Details |
2022-10-17 20:40:56 -0500 | F7A4FC95E7E28A832C3C4564C2F9FAB3 | Rating Details |
2022-10-17 20:40:56 -0500 | F9C81045EEB52DA14526E5476ED03D7E98BA35B1A88FC1BEF9745C002EA8B37E | Rating Details |
2022-10-17 21:34:37 -0500 | FBD4C539ADDD48521B69767302DD70B1 | Rating Details |
2022-10-18 08:53:19 -0500 | FF7D24028DC305C19E1CC5D2DF9E51AF7040B75175B3619FBAF4519D13DDCB1B | Rating Details |
2022-10-17 19:51:27 -0500 | Rating Details | |
2022-10-17 20:40:56 -0500 | Rating Details | |
2022-10-18 07:54:01 -0500 | Rating Details | |
2022-10-22 19:50:42 -0500 | Rating Details | |
2022-10-17 19:40:09 -0500 | Rating Details | |
2022-10-17 19:39:15 -0500 | Rating Details | |
2022-10-17 16:43:40 -0500 | Rating Details | |
2022-10-18 16:54:55 -0500 | Rating Details | |
2022-10-18 13:55:46 -0500 | Rating Details | |
2022-10-18 08:53:19 -0500 | Rating Details | |
2022-10-17 23:23:06 -0500 | Rating Details | |
2022-10-17 20:59:23 -0500 | Rating Details | |
2022-10-17 17:19:06 -0500 | Rating Details | |
2022-10-17 18:57:04 -0500 | Rating Details | |
2022-10-18 02:07:26 -0500 | Rating Details | |
2022-10-17 21:01:00 -0500 | Rating Details | |
2022-10-18 07:10:36 -0500 | Rating Details | |
2022-10-17 19:51:27 -0500 | Rating Details |